These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hydroa vacciniforme-like lymphoproliferative disorder: A retrospective study on clinicopathological characteristics of 32 cases. Xu W, Tan J, Cai C, Lei L, Cao X, Zhou H, Xu M. Pediatr Dermatol; 2022 May; 39(3):372-375. PubMed ID: 35194837 [Abstract] [Full Text] [Related]
7. Hydroa vacciniforme lymphoproliferative disorder: a retrospective study of 42 paediatric cases. Zhang Y, Liu Y, Xu J, Liang Y, Xu Z. Eur J Dermatol; 2024 Apr 01; 34(2):144-149. PubMed ID: 38907544 [Abstract] [Full Text] [Related]
8. Hydroa vacciniforme-like lymphoproliferative disorder in an elderly Chinese patient and a literature review of adult cases. Long V, Liang MW, Tan SH. Int J Dermatol; 2018 Nov 01; 57(11):1283-1292. PubMed ID: 29926891 [Abstract] [Full Text] [Related]
9. Hydroa vacciniforme-like lymphoproliferative disorder in Ecuadorian children: A case series. Garzón E, Dávila-Rodríguez JJ. Indian J Dermatol Venereol Leprol; 2023 Nov 01; 89(3):403-407. PubMed ID: 33871198 [Abstract] [Full Text] [Related]
18. Hydroa vacciniforme-like Epstein-Barr virus-associated lymphoproliferative disease: a case report. Zeng Y, Fu L, Jin H, Sun Q, Wang B. Pediatr Dermatol; 2012 Dec 01; 29(1):96-100. PubMed ID: 21995788 [Abstract] [Full Text] [Related]
19. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases. Guo N, Chen Y, Wang Y, Huang Y, Feng Y, Li M, Rao H. Diagn Pathol; 2019 Jul 17; 14(1):82. PubMed ID: 31315684 [Abstract] [Full Text] [Related]
20. Antiviral treatment of a boy with EBV-associated hydroa vacciniforme. Pahlow Mose A, Fisker N, Clemmensen O, Bygum A. BMJ Case Rep; 2014 Nov 24; 2014():. PubMed ID: 25422336 [Abstract] [Full Text] [Related] Page: [Next] [New Search]